IL133920A0 - Trail receptor - Google Patents
Trail receptorInfo
- Publication number
- IL133920A0 IL133920A0 IL13392098A IL13392098A IL133920A0 IL 133920 A0 IL133920 A0 IL 133920A0 IL 13392098 A IL13392098 A IL 13392098A IL 13392098 A IL13392098 A IL 13392098A IL 133920 A0 IL133920 A0 IL 133920A0
- Authority
- IL
- Israel
- Prior art keywords
- trail receptor
- trail
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89211997A | 1997-07-15 | 1997-07-15 | |
PCT/US1998/014410 WO1999003992A1 (en) | 1997-07-15 | 1998-07-10 | Trail receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
IL133920A0 true IL133920A0 (en) | 2001-04-30 |
Family
ID=25399402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13392098A IL133920A0 (en) | 1997-07-15 | 1998-07-10 | Trail receptor |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0998561A4 (en) |
JP (1) | JP2001510042A (en) |
AU (1) | AU8395798A (en) |
CA (1) | CA2295719A1 (en) |
IL (1) | IL133920A0 (en) |
NZ (1) | NZ501951A (en) |
WO (1) | WO1999003992A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506569B1 (en) | 1997-05-30 | 2003-01-14 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor TR10 |
WO1998054202A1 (en) | 1997-05-30 | 1998-12-03 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr10 |
US6252050B1 (en) | 1998-06-12 | 2001-06-26 | Genentech, Inc. | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |
EP1187842B1 (en) * | 1999-05-28 | 2006-04-26 | Human Genome Sciences, Inc. | Fc fusion proteins of the HUMAN TUMOR NECROSIS FACTOR RECEPTOR TR10 |
US6627199B1 (en) | 1999-07-09 | 2003-09-30 | Amgen Inc | Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family |
AU783682B2 (en) | 1999-08-04 | 2005-11-24 | Amgen, Inc. | Fhm, a novel member of the TNF ligand supergene family |
AU6517800A (en) | 1999-08-04 | 2001-03-05 | Amgen, Inc. | Ntr3, a member of the tnf-receptor supergene family |
US7279160B2 (en) | 2000-05-02 | 2007-10-09 | The Uab Research Foundation | Combinations of DR5 antibodies and other therapeutic agents |
TWI318983B (en) * | 2000-05-02 | 2010-01-01 | Uab Research Foundation | An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
US7476383B2 (en) | 2000-05-02 | 2009-01-13 | The Uab Research Foundation | Antibody selective for DR4 and uses thereof |
KR100436089B1 (en) * | 2000-07-06 | 2004-06-14 | 설대우 | DNA cassette for the production of secretable recombinant trimeric TRAIL protein, Tetracycline/Doxycycline-inducible Adeno-associated virus(AAV), and combination of both and the gene therapy method thereof |
KR20020056565A (en) * | 2000-12-29 | 2002-07-10 | 황규언 | Three-dimensional structure of human derived apoptotic factor and receptor thereof by X-ray chrystallography and TRAIL deletion mutant protein |
KR100942393B1 (en) | 2001-05-25 | 2010-02-17 | 휴먼 게놈 사이언시즈, 인코포레이티드 | Antibodies that immunospecifically bind to TRAIL receptors |
BRPI0606791A2 (en) | 2005-02-02 | 2010-02-09 | Uab Research Foundation | methods of reversing or preventing the resistance of a cell to a death receptor agonist, of screening a cell for a biomarker of resistance to a death receptor agonist, of monitoring resistance to a death receptor agonist in an individual , to selectively induce apoptosis in a target cell expressing a death receptor, to treat an individual with cancer, to treat an individual with an inflammatory or autoimmune disease, to block the binding of the card-containing protein to a death receptor in a cell, to block the association of an iap with the death receptor and to screen a modulator of a protein containing card, composition, isolated nucleic acid, vector, cell, and isolated polypeptide |
KR20120101050A (en) | 2009-11-05 | 2012-09-12 | 더 유에이비 리서치 파운데이션 | Treating basal-like genotype cancers |
WO2011116344A2 (en) | 2010-03-18 | 2011-09-22 | The Uab Research Foundation | Targeting cancer stem cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054202A1 (en) * | 1997-05-30 | 1998-12-03 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr10 |
DK1009817T3 (en) * | 1997-08-26 | 2010-01-18 | Genentech Inc | RTD receptor |
-
1998
- 1998-07-10 EP EP98934441A patent/EP0998561A4/en not_active Withdrawn
- 1998-07-10 AU AU83957/98A patent/AU8395798A/en not_active Abandoned
- 1998-07-10 IL IL13392098A patent/IL133920A0/en unknown
- 1998-07-10 WO PCT/US1998/014410 patent/WO1999003992A1/en not_active Application Discontinuation
- 1998-07-10 JP JP2000503198A patent/JP2001510042A/en active Pending
- 1998-07-10 CA CA002295719A patent/CA2295719A1/en not_active Abandoned
- 1998-07-10 NZ NZ501951A patent/NZ501951A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0998561A4 (en) | 2004-08-18 |
EP0998561A1 (en) | 2000-05-10 |
AU8395798A (en) | 1999-02-10 |
WO1999003992A1 (en) | 1999-01-28 |
NZ501951A (en) | 2001-09-28 |
JP2001510042A (en) | 2001-07-31 |
CA2295719A1 (en) | 1999-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL335999A1 (en) | Substituted 3-cyanoquinolines | |
AP2000001795A0 (en) | Substituted 4-aminothiazol-2-yol | |
EP1007563A4 (en) | Hm74a receptor | |
HK1029035A1 (en) | Teeth-cleansing means | |
IL133920A0 (en) | Trail receptor | |
ZA979060B (en) | Receptor selective BNP | |
EP0929218A4 (en) | P2y receptor antagonists | |
AU7132898A (en) | Edg-1-like receptor | |
GB9617923D0 (en) | Novel receptor | |
EP1084142A4 (en) | Gpr35a receptor | |
EP0973800A4 (en) | Novel receptor | |
PL334546A1 (en) | Substituted 4-benzoylpyrazoles | |
GB9819420D0 (en) | Novel receptor | |
GB9708254D0 (en) | Construction system | |
EP1083909A4 (en) | hCEPR RECEPTOR | |
GB9708589D0 (en) | Seurity means | |
GB9721974D0 (en) | Construction fitting | |
ZA985761B (en) | Substituted aryluracils | |
IL133261A0 (en) | Substituted naphthropyrans | |
EP1109565A4 (en) | Gabab1aa receptor | |
IL183048A0 (en) | Receptor that binds trail | |
ZA987267B (en) | Nucleosides | |
GB9719470D0 (en) | Nocotinic receptors | |
GB9700894D0 (en) | Eosinophil eotain receptor | |
GB9825849D0 (en) | Receptor |